<DOC>
	<DOCNO>NCT01020279</DOCNO>
	<brief_summary>1 . Comparison effect ketoprofen Transfersome® gel ( KTG ) placebo gel ( PG ) muscle pain calf cause eccentric contraction 2 . Comparison effect KTG celecoxib ( CE ) muscle pain calf cause eccentric contraction 3 . Comparison effect celecoxib ( CE ) oral placebo ( OP ) muscle pain calf cause eccentric contraction</brief_summary>
	<brief_title>Study Epicutaneously Applied Ketoprofen Transfersome® Gel With Without Combination With Oral Celecoxib Treatment Muscle Pain Induced Eccentric Exercise</brief_title>
	<detailed_description />
	<mesh_term>Musculoskeletal Pain</mesh_term>
	<mesh_term>Myalgia</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Signed date informed consent prior participation Subjects good health determine Investigator Age 1855 Willing abstain physical therapy , hard physical work , exercise sauna study observation period ( Screening Final Visit ) For female , subject childbearing potential ( include perimenopausal woman menstrual period within 1 year ) must use appropriate birth control ( define method result low failure rate , i.e. , less 1 % per year use consistently correctly , implant , injectables , intrauterine contraceptive device ( IUDs ) , sexual abstinence , vasectomized partner ) . Oral contraceptive medication allow study . Female subject , surgically sterile ( bilateral tubal ligation , bilateral oophorectomy hysterectomy ) also allow participation Participation another clinical study within last 30 day study Subjects inmates psychiatric ward , prison , state institution Investigator team member involve directly indirectly conduct clinical study Pregnancy lactation Alcohol drug abuse Malignancy within past 2 year exception situ removal basal cell carcinoma Skin lesion , dermatological disease tattoo treatment area Known hypersensitivity allergy ( include photoallergy ) NSAID´s include celecoxib , sulfonamides ingredient use pharmaceutical product cosmetic include galactose Varicosis , thrombophlebitis vascular disorder low extremity Major traumatic lesion ( e.g . fracture , tendon muscle rupture ) musculoskeletal system lower limb Pain condition might interfere pain rating study , e.g . neuropathic pain Significant neurological psychiatric symptom result disorientation , memory impairment , inability report accurately ( e.g . Alzheimer 's disease schizophrenia psychosis ) , investigator 's opinion may affect efficacy safety assessment may compromise subject safety study Systemic lupus erythematodes , mixed connective tissue disease Major heart disease / uncontrollable hypertension Peripheral arterial disease and/or cerebrovascular disease History stroke myocardial infarction GFR &lt; 30 ml/min ALT and/or AST level ≥ 5 time ULN Chronic obstructive pulmonary disease include asthma bronchiale Coagulopathy bleeding diathesis , concomitant use anticoagulant include low dose aspirin History pancreatitis peptic ulcer Inflammatory GI disease ( e.g . M. Crohn , colitis ulcerosa ) Reflux esophagitis require treatment Any analgesic therapy include cough cold drug contain analgesic property well substance use treatment pain study observation period ( Screening final Visit ) Any drug might alter pain perception like CNS active drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>muscle pain</keyword>
	<keyword>model</keyword>
</DOC>